Descriptive Analytics Market 2016-2022 - Global Market

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Descriptive Analytics Market 2016-2022 - Global Market Drivers, Opportunities, Trends, and Forecasts

Dublin, July 27, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Descriptive Analytics Market - By Verticals, Regions, Global Market Drivers, Opportunities, Trends, and Forecasts, 2016-2022" report to their offering. The descriptive analytics market is expected to grow at a CAGR of 18.2% during the period 2016-2022.

Over the past few years, there is a drastic increase in the volume of data due to increasing adoption of digital technology, big data, and advanced technologies in all the industries. The enterprises are aggressively moving towards adoption of analytics techniques to analyse structured and unstructured data and get the valuable insights to make better decisions. The descriptive analytics provides valuable information about the past business failure or success. These insights help the business to make better business plans and make success in the future business. The descriptive analytics tools are being widely adopted in all the industry sectors and are the primary elements in analytics tree. The increasing adoption of digital technologies, the need of analytics, increasing return on investments (ROI), and a huge amount of data creation have led the organizations to adopt descriptive analytics. The descriptive analytics market is analyzed based on verticals and regions. Verticals include BFSI, Retail & Consumer Goods, and Healthcare, Telecom and Energy & Utilities and others. Globally, BFSI and Retail verticals are set to be the major verticals and are contributing more than 42% of the market share in 2016 and Healthcare industry is set to be the emerging market in the next six to seven years. In addition, customer analytics and risk analytics are expected to outperform for analytics market growth in every industry sector followed by financial analytics and sales & marketing analytics. The increasing spending on advance technologies, digital technologies, Internet of Things (IoT) are few major drivers expected to support the descriptive analytics market. The report also helps in getting complete picture (vertical market opportunity, regional market opportunity, challenges, current market trends, future market trends, evolution, technology road map, etc.) of the descriptive analytics. The key players covered in the report are IBM, Oracle, Dell, Accenture, TCS, Infosys, SAP, Microsoft, etc. The study covers and analyses the Descriptive Analytics market globally. Bringing out the complete key insights of the industry, the report aims to provide an opportunity for players to understand the latest trends, current market scenario, and technologies related to the market. In addition, helps the venture capitalist in understanding the companies better and take informed decisions. Key Topics Covered: 1 Industry Outlook 2 Report Outline 3 Market Snapshot 4 Market Outlook 5 Market Characteristics 6 Descriptive Analytics in BFSI: Market Size and Analysis 7 Descriptive Analytics in Retail & Consumer Goods: Market Size and Analysis 8 Descriptive Analytics in Telecom: Market Size and Analysis 9 Descriptive Analytics in Healthcare: Market Size and Analysis

10 Descriptive Analytics in Energy & Utilities: Market Size and Analysis 11 Regions: Market Size and Analysis 12 Vendor Profiles 13 Global Generalist 14 Competitive Landscape Companies Mentioned - Accenture Plc. - Dell Inc. - EMC Corp. - FICO - Hewlett-Packard Co. - IBM Corp. - Microsoft Corp. - MicroStrategy Inc. - Oracle Corp. - SAP - SAS Institute Inc. - Tableau Software Inc. - Tata Consultancy Services Limited - TIBCO Software Inc. For more information visit http://www.researchandmarkets.com/research/k7...escriptive

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Computing and Technology

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading